IBDEI0HJ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8484,0)
 ;;=871.4^^52^582^54
 ;;^UTILITY(U,$J,358.3,8484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8484,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,8484,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,8484,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,8485,0)
 ;;=242.90^^52^582^108
 ;;^UTILITY(U,$J,358.3,8485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8485,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,8485,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,8485,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,8486,0)
 ;;=135.^^52^582^101
 ;;^UTILITY(U,$J,358.3,8486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8486,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,8486,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,8486,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,8487,0)
 ;;=446.5^^52^582^107
 ;;^UTILITY(U,$J,358.3,8487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8487,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,8487,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,8487,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,8488,0)
 ;;=401.9^^52^582^49
 ;;^UTILITY(U,$J,358.3,8488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8488,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,8488,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,8488,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,8489,0)
 ;;=V72.0^^52^582^32
 ;;^UTILITY(U,$J,358.3,8489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8489,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,8489,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,8489,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,8490,0)
 ;;=V41.0^^52^582^91
 ;;^UTILITY(U,$J,358.3,8490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8490,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,8490,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,8490,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,8491,0)
 ;;=998.59^^52^582^89
 ;;^UTILITY(U,$J,358.3,8491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8491,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,8491,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,8491,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,8492,0)
 ;;=042.^^52^582^1
 ;;^UTILITY(U,$J,358.3,8492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8492,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,8492,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,8492,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,8493,0)
 ;;=053.29^^52^582^43
 ;;^UTILITY(U,$J,358.3,8493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8493,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,8493,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,8493,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,8494,0)
 ;;=054.40^^52^582^42
 ;;^UTILITY(U,$J,358.3,8494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8494,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,8494,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,8494,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,8495,0)
 ;;=190.1^^52^582^83
 ;;^UTILITY(U,$J,358.3,8495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8495,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,8495,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,8495,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,8496,0)
 ;;=190.2^^52^582^50
 ;;^UTILITY(U,$J,358.3,8496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8496,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,8496,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,8496,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,8497,0)
 ;;=190.7^^52^582^52
 ;;^UTILITY(U,$J,358.3,8497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8497,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,8497,1,4,0)
 ;;=4^190.7
